Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: Potential for autocrine and paracrine networks
- 30 September 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (9) , 1076-1081
- https://doi.org/10.1016/s0301-472x(01)00682-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Characterization of osteoclast precursors in human bloodBritish Journal of Haematology, 2000
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myelomaEuropean Journal of Haematology, 2000
- Human myeloma cells express the CD38 ligand CD31British Journal of Haematology, 1999
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell lineEuropean Journal of Haematology, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- A Monoclonal Anti-Human IL-6 Receptor Antibody Inhibits the Proliferation of Human Myeloma CellsHybridoma, 1993
- Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivoEuropean Journal of Immunology, 1992
- Bone marrow histology and serum beta 2 microglobulin in multiple myeloma — a new prognostic strategyEuropean Journal of Haematology, 1989